Related Experiment Video
Updated: Feb 11, 2026

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
Published on: February 2, 2022
[Prevention of mouse corneal allograft rejection by micromolecular compound J2]
Da-jiang Wang1, Yi-fei Huang, Han Zhang
1Ophthalmic Center of PLA, Department of Ophthalmology, General Hospital of PLA, Beijing 100853, China.
Objective:
To investigate the effects of J2 on the prevention of corneal allograft rejection in mice.
Methods:
Randomized control design was applied. One hundred C57BL/6 and thirty eight BALB/c mice were used as donors and recipients, respectively, to establish a corneal allograft model. These mice were randomly divided into A, B, C and D groups. There were 25 mice in each group. Group A, autograft control; Group B, allograft control (placebo was used in this group); Group C, allograft and treated with intraperitoneal ciclosporin A (CsA, 10 mg * kg(-1) * d(-1)) and Group D, allograft and treated with intraperitoneal J2 (15 mg * kg(-1) * d(-1)). All medications were applied on the day of transplantation and were continuously administrated for 12 days. Graft survival index, paraffin sections with HE staining and immunohistochemical staining of frozen sections were observed in each group 1, 2, 3 and 4 weeks after operation. IL-2 and IL-10 expression of cornea was detected by RT-PCR. One-Way ANOVO analysis was used to compare transplant survival time of the corneal allograft of each group.
Results:
The average transplant survival time in the corneal allograft controls was (18.88 +/- 4.19) d. Treatment with J2 resulted in a significant increase of grafts' survival time (33.62 +/- 6.80) d (q = 0.85, P < 0.01). There was no significant difference between J2 and CsA groups. Histological examination showed that numerous lymphocytes infiltrated into the grafts 21 days after the operation in the control groups. Mild lymphocytes infiltration was found in both CsA and J2 groups. Immunohistochemical studies showed that large amount of CD4(+) and CD8(+) T-lymphocytes infiltrated into the grafts of the placebo group at 21 days. J2 and CsA groups only showed a small number of CD4(+) and CD8(+) T-lymphocytes in the grafts. RT-PCR showed that few IL-2 and IL-10 genes were expressed in the autologous transplantation group in the first week, and the expression of these two cytokines showed no significant increase during following three weeks. Both genes were expressed from the first week in the allogeneic transplantation group and significantly increased in the third week. Both genes were expressed from the first week in CsA and J2 group, expression was reduced in the second and third weeks. Expression of these cytokines in the fourth week was stronger than those in previous three weeks.
Conclusion:
J2 can inhibit corneal rejection in allograft mice model and its effect is similar to that of CsA.
Insights
The novel compound J2 effectively prevents corneal allograft rejection in mice, demonstrating efficacy comparable to ciclosporin A. This finding offers a promising new avenue for inhibiting transplant rejection.
Area of Science:
- Immunology
- Transplantation immunology
- Ophthalmology
Context:
- Corneal transplantation is crucial for vision restoration.
- Allograft rejection remains a significant challenge in transplantation.
- Developing effective immunosuppressive strategies is vital.
Purpose:
- To evaluate the efficacy of J2 in preventing corneal allograft rejection in a murine model.
- To compare J2's effects with ciclosporin A (CsA) and placebo controls.
Summary:
- J2 treatment significantly prolonged corneal graft survival compared to placebo.
- Histological and immunohistochemical analyses revealed reduced lymphocyte infiltration in J2-treated grafts.
- J2 modulated the expression of key inflammatory cytokines (IL-2 and IL-10).
Impact:
- J2 demonstrates potential as a novel therapeutic agent for preventing corneal allograft rejection.
- The findings suggest J2 could offer an alternative immunosuppressive strategy.
- Further research may explore J2's clinical applicability in transplantation.
Related Concept Videos
Cancer Prevention
Some...
Molecules and Compounds
Organic Compounds
Hypothesis: Accept or Fail to Reject?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
Quantifying and Rejecting Outliers: The Grubbs Test
Elements and Compounds
Elements
Elements are classified as atomic or molecular based on the nature of their basic units. They are unique forms of matter with specific chemical and physical properties that cannot break down into smaller substances by ordinary chemical reactions. There...

